Ottawa getting $40 million refund from former parent company of Quebec COVID vaccine maker
Ottawa will be getting a $40 million refund after it gave Quebec City-based biopharmaceutical company Medicago more than $300 million to develop and manufacture a home-grown COVID-19 vaccine that never made it to market.
Ottawa will be getting a $40 million refund after it gave Quebec City-based biopharmaceutical company Medicago more than $300 million to develop and manufacture a home-grown COVID-19 vaccine that never made it to market.
